These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 28566376)
21. Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer. Liu YP; Steele MB; Suksanpaisan L; Federspiel MJ; Russell SJ; Peng KW; Bakkum-Gamez JN Gynecol Oncol; 2014 Jan; 132(1):194-202. PubMed ID: 24246772 [TBL] [Abstract][Full Text] [Related]
22. Multiomic Profiling Identified EGF Receptor Signaling as a Potential Inhibitor of Type I Interferon Response in Models of Oncolytic Therapy by Vesicular Stomatitis Virus. Nikitina AS; Lipatova AV; Goncharov AO; Kliuchnikova AA; Pyatnitskiy MA; Kuznetsova KG; Hamad A; Vorobyev PO; Alekseeva ON; Mahmoud M; Shakiba Y; Anufrieva KS; Arapidi GP; Ivanov MV; Tarasova IA; Gorshkov MV; Chumakov PM; Moshkovskii SA Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563635 [TBL] [Abstract][Full Text] [Related]
23. Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer. Geoffroy K; Mullins-Dansereau V; Leclerc-Desaulniers K; Viens M; Bourgeois-Daigneault MC Mol Ther Oncol; 2024 Sep; 32(3):200826. PubMed ID: 39006945 [TBL] [Abstract][Full Text] [Related]
24. Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors. Escobar-Zarate D; Liu YP; Suksanpaisan L; Russell SJ; Peng KW Cancer Gene Ther; 2013 Oct; 20(10):582-9. PubMed ID: 24030211 [TBL] [Abstract][Full Text] [Related]
25. Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer. Hastie E; Grdzelishvili VZ J Gen Virol; 2012 Dec; 93(Pt 12):2529-2545. PubMed ID: 23052398 [TBL] [Abstract][Full Text] [Related]
26. Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus. Carey BL; Ahmed M; Puckett S; Lyles DS J Virol; 2008 Dec; 82(24):12104-15. PubMed ID: 18829743 [TBL] [Abstract][Full Text] [Related]
27. Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma. Hastie E; Besmer DM; Shah NR; Murphy AM; Moerdyk-Schauwecker M; Molestina C; Roy LD; Curry JM; Mukherjee P; Grdzelishvili VZ J Virol; 2013 Sep; 87(18):10283-94. PubMed ID: 23864625 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4. Moon J; Kaowinn S; Cho IR; Min DS; Myung H; Oh S; Kaewpiboon C; Kraemer OH; Chung YH Biochem Biophys Res Commun; 2016 Jun; 474(3):428-434. PubMed ID: 27150631 [TBL] [Abstract][Full Text] [Related]
29. Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors. Wollmann G; Drokhlyansky E; Davis JN; Cepko C; van den Pol AN J Virol; 2015 Jul; 89(13):6711-24. PubMed ID: 25878115 [TBL] [Abstract][Full Text] [Related]